Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humagen is a specialized life sciences company primarily known for its development and manufacture of high-quality micropipettes and accessories used in Assisted Reproductive Technology (ART). Founded in 1992 and based in Charlottesville, Virginia, the company became a global leader in the IVF market, specifically for Intracytoplasmic Sperm Injection (ICSI) and embryo biopsy tools. The company's product line includes precision-engineered glass microtools that are essential for the micromanipulation of gametes and embryos. In 2008, Humagen was acquired by the Danish company Origio A/S, which was later acquired by The Cooper Companies. Today, the Humagen brand is integrated into the CooperSurgical Fertility and Genomic Solutions portfolio, continuing to serve fertility clinics and research laboratories worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humagen.